TY - GEN
T1 - Pulsed transmission waveform to mitigate tissue thermal effects in transcutaneous wireless energy supply systems for high-power rated medical implants
AU - Escalona, OJ
AU - Waterman, Niall
AU - McLaughlin, James
AU - McEneaney, David
PY - 2018/5/30
Y1 - 2018/5/30
N2 - Therapeutic options in end stage heart failure include cardiac transplantation or mechanical circulatory support: Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH). These devices have relatively high power requirements (5-80W). Existing power supplies to LVAD and TAH are via percutaneous drivelines with a high frequency of complications including infection. We have developed a wireless Transcutaneous Energy Transmission (TET) waveform protocol and system technology which address the major clinical drawbacks of existing systems: skin tissue thermal effect and system durability. Conventional single-channel TET solutions have significant limitations, including inefficient energy transfer characteristics and high energy density levels producing tissue thermal effects. A reduced lifetime of the internal rechargeable battery is an additional drawback. In the proposed novel system, a multi-channel, time-space multiplexed and pulsed RF transmission waveform transcutaneous power delivery approach, is presented for sustained internal energy supply to high-power rated implantable devices. The bench system prototype performance evaluation results, revealed excellent high-energy transfer efficiency and safer management of lower energy density levels. In conclusion, the proposed pulsed transmission waveform protocol and multi-channel concepts can be configured for individual high-power rated LVAD devices to effectively mitigate tissue thermal effects and to prolong backup battery lifetime.
AB - Therapeutic options in end stage heart failure include cardiac transplantation or mechanical circulatory support: Left Ventricular Assist Device (LVAD) or Total Artificial Heart (TAH). These devices have relatively high power requirements (5-80W). Existing power supplies to LVAD and TAH are via percutaneous drivelines with a high frequency of complications including infection. We have developed a wireless Transcutaneous Energy Transmission (TET) waveform protocol and system technology which address the major clinical drawbacks of existing systems: skin tissue thermal effect and system durability. Conventional single-channel TET solutions have significant limitations, including inefficient energy transfer characteristics and high energy density levels producing tissue thermal effects. A reduced lifetime of the internal rechargeable battery is an additional drawback. In the proposed novel system, a multi-channel, time-space multiplexed and pulsed RF transmission waveform transcutaneous power delivery approach, is presented for sustained internal energy supply to high-power rated implantable devices. The bench system prototype performance evaluation results, revealed excellent high-energy transfer efficiency and safer management of lower energy density levels. In conclusion, the proposed pulsed transmission waveform protocol and multi-channel concepts can be configured for individual high-power rated LVAD devices to effectively mitigate tissue thermal effects and to prolong backup battery lifetime.
KW - Transcutaneous energy transfer
KW - TWESMI Technology
KW - pulsed RF transmission waveform
KW - chronic cardiac failure
KW - ventricular assist device
KW - LVAD
KW - heart transplant
KW - tissue temperature stability
KW - medical implants
UR - https://link.springer.com/chapter/10.1007%2F978-981-10-9038-7_175
UR - https://doi.org/10.1007/978-981-10-9038-7_175
M3 - Conference contribution
SN - 978-981-10-9037-0
VL - 68/2
SP - 945
EP - 950
BT - IFMBE Proceedings
PB - Springer
CY - Singapore
T2 - World Congress on Medical Physics and Biomedical Engineering
Y2 - 3 June 2018 through 8 June 2018
ER -